HIGHLIGHTS
- What: The aims of this study were to report the incidence of both TCMR and ABMR (antibodymediated rejection) after conversion to belatacept in a rescue strategy, to depict the evolution of these patients and to identify factors associated with the occurrence of TCMR after conversion.
- Who: CNI toxicity and colleagues from the Department of Nephrology, and Hemodialysis, Rouen University, Rouen, France, Department have published the research: Biopsy-Proven T-Cell Mediated Rejection After Belatacept Rescue Conversion: A Multicenter Retrospective Study, in the Journal: (JOURNAL)
- How: The authors designed a multicenter retrospective study in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.